Prostate contouring using CT alone is difficult. To overcome the uncertainty, CT/MRI registration using a fiducial marker is generally performed. However, visualization of the marker itself can be difficult with MRI. This study aimed to determine the optimal MRI pulse sequence for defining the marker as well as the prostate outline among five sequences.A total of 21 consecutive patients with prostate cancer were enrolled. Two gold fiducial markers were placed before CT/MRI examination. We used the following five sequences: T1-weighted spin-echo (T1WI; TR/TE, 400-650/8 ms); T2-weighted fast spin-echo (T2WI; 4000/80); T2*-2D-weighted gradient echo (T2*2D; 700/18); T2*-3D-weighted gradient echo (T2*3D; TR/TE1/deltaTE, 37/14/7.3); and contrast-...
PURPOSE: To compare 3D T1-weighted fast spin echo (FSE) and 3D T1-weighted gradient echo (GE) mDixon...
OBJECTIVE: Visualizing the gold marker (GM) in CT and MRI is critical, especially for registration i...
Background: The evidence supporting the use of magnetic resonance imaging (MRI) in prostate cancer d...
AimProstate contouring using CT alone is difficult. To overcome the uncertainty, CT/MRI registration...
When performing intensity-modulated radiotherapy for prostate cancer, a marker is inserted into the ...
Background and purpose Intraprostatic fiducial markers (FM) improve the accuracy of radiotherapy (RT...
Purpose: The superior soft tissue contrast of magnetic resonance imaging (MRI) compared to computed ...
Background and purpose: The introduction of a magnetic resonance (MR)-only workflow in radiotherapy ...
Contains fulltext : 47372.pdf (publisher's version ) (Closed access)The use of int...
Purpose:To compare diagnostic accuracy of T2-weighted magnetic resonance (MR) imaging with that of m...
Abstract Background: The benefit of MR-only workflow compared to current CT-based workflow for pros...
BACKGROUND: The use of intraprostatic gold fiducial markers (FMs) ensures highly accurate and precis...
PURPOSE: To evaluate which parameters of dynamic magnetic resonance (MR) imaging and T2 relaxation r...
Purpose: The feasibility of radiation therapy treatment planning using substitute computed tomograph...
Background: The evidence supporting the use of magnetic resonance imaging (MRI) in prostate cancer d...
PURPOSE: To compare 3D T1-weighted fast spin echo (FSE) and 3D T1-weighted gradient echo (GE) mDixon...
OBJECTIVE: Visualizing the gold marker (GM) in CT and MRI is critical, especially for registration i...
Background: The evidence supporting the use of magnetic resonance imaging (MRI) in prostate cancer d...
AimProstate contouring using CT alone is difficult. To overcome the uncertainty, CT/MRI registration...
When performing intensity-modulated radiotherapy for prostate cancer, a marker is inserted into the ...
Background and purpose Intraprostatic fiducial markers (FM) improve the accuracy of radiotherapy (RT...
Purpose: The superior soft tissue contrast of magnetic resonance imaging (MRI) compared to computed ...
Background and purpose: The introduction of a magnetic resonance (MR)-only workflow in radiotherapy ...
Contains fulltext : 47372.pdf (publisher's version ) (Closed access)The use of int...
Purpose:To compare diagnostic accuracy of T2-weighted magnetic resonance (MR) imaging with that of m...
Abstract Background: The benefit of MR-only workflow compared to current CT-based workflow for pros...
BACKGROUND: The use of intraprostatic gold fiducial markers (FMs) ensures highly accurate and precis...
PURPOSE: To evaluate which parameters of dynamic magnetic resonance (MR) imaging and T2 relaxation r...
Purpose: The feasibility of radiation therapy treatment planning using substitute computed tomograph...
Background: The evidence supporting the use of magnetic resonance imaging (MRI) in prostate cancer d...
PURPOSE: To compare 3D T1-weighted fast spin echo (FSE) and 3D T1-weighted gradient echo (GE) mDixon...
OBJECTIVE: Visualizing the gold marker (GM) in CT and MRI is critical, especially for registration i...
Background: The evidence supporting the use of magnetic resonance imaging (MRI) in prostate cancer d...